NCT06946433Completed
tDCS in Adults With ASD and/or ADHD Without Intellectual Disability
Ensayo clínico Fase 1 de tDCS en Adultos Con TEA y/o TDAH Sin Discapacidad Intelectual
Source: ClinicalTrials.gov · Last updated 1 Aug 2025
Brief summary (registry, in English)
The goal of this clinical trial is to learn about the safety and tolerability of transcranial direct current stimulation (tDCS) combined with cognitive training in adults with Autism Spectrum Disorder (ASD) and/or Attention-Deficit/Hyperactivity Disorder (ADHD). The main question it aims to answer is: Is tDCS safe and well-tolerated in adults with ASD and/or ADHD? Researchers will compare active tDCS to a sham (placebo-like) stimulation to evaluate safety and tolerability. Participants will: Receive either active or sham tDCS for 20 minutes daily over 10 consecutive workdays Undergo stimulation with the anode placed at F3 and the cathode at Fp2 Complete daily cognitive training exercises using the NeuronUP platform during stimulation Attend baseline and follow-up assessments to monitor for any side effects or discomfort related to the intervention
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 25 (actual)
- First submitted
- 8 Apr 2025
- Start date
- 7 Nov 2022
- Primary completion date
- 19 Jan 2024
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Diseases
- Autism
- NCT number
- NCT06946433
What you commit to
- Study type: Interventional
- Participants enrolled: 25
- From 7 Nov 2022 to the primary completion date, 19 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Presence of metal implants in the head (excluding dental work), pacemaker, or other contraindications to tDCS
Other illness
- History of epilepsy, seizures, or significant neurological disorder (e.g., traumatic brain injury, stroke)
- Current diagnosis of psychotic disorder or bipolar disorder
- Current substance use disorder (within past 6 months)
- Any condition that, in the opinion of the investigators, may make participation unsafe or interfere with study procedures
Other
- Pregnant or planning to become pregnant during the study period
- Participation in another intervention study within the last 30 days
Who the study is looking for
- Adults aged 18 to 55 years
- Clinical diagnosis of Autism Spectrum Disorder (ASD) and/or Attention-Deficit/Hyperactivity Disorder (ADHD) confirmed via medical records or structured clinical interview
- Able to provide informed consent
- Fluent in the language used for assessments and cognitive training tasks
- Stable medication regimen (if applicable) for at least 4 weeks prior to enrollment
- Willing and able to attend 10 consecutive weekday sessions and follow-up assessment
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitari Vall d'Hebron Coordinator of this site? Confirm its status | Barcelona | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.